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http://dx.doi.org/10.1016/j.jmii.2012Influenza virus infection causes endemics almost yearly and pandemics occasionally. Although
antivirals are available for the clinical treatment of influenza virus infection, the emergence of
a drug-resistant virus has reduced the effectiveness of therapy and prophylaxis. Therefore, the
timely detection of drug-resistant influenza viruses is important. A single-tube reaction using
peptide nucleic acid (PNA) as both a polymerase chain reaction (PCR) clamp and a sensor probe
was established to detect the low numbers of copies of viral genes that carry the resistant
marker. Influenza A H1N1 viruses resistant to a clinically used antiviral, amantadine, are
selected for the experimental design. The PNA-mediated reverse transcription-PCR detected
10 copies/mL of RNA from the resistant strain among 2  104 copies/mL of RNA from the sensi-
tive strain. A rapid and sensitive method was established for detecting low numbers of drug-
resistant genes of the influenza virus. The assay would help to monitorthe emergence of
adrug-resistant influenza virus.
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Detecting drug-resistant influenza A H1N1 viruses 255Influenza virus infection causes high mortality and
morbidity in humans and animals. This virus belongs to RT-PCR of M2 gene was performed using Qiagen One-Step RT-Figure 1. Sensitivity of detecting the amantadine-resistant
H1N1 virus by PNA-mediated PCR amplification (clamping).
Filled and open arrowheads indicate the melting peaks of wild-
type and mutant, respectively.orthomyxoviridae, a family of RNA viruses. Like other RNA
viruses, there is no proofreading activity of viral RNA
polymerase so that mutant viruses are easily generated and
form a quasispecies in virus population. A rare amount of
mutant viruses is generally undetectable by reverse
transcription-polymerase chain reaction (RT-PCR) because
the reaction would amplify the major form of RNA that
derived from wild-type viruses. However, the undetectable
mutant viruses would sometimes cause severe clinical
impacts. Therefore, it is important to detect the low copies
of drug-resistant mutant RNA in clinical specimens to avoid
the emergence of drug-resistant mutant viruses.
Peptide nucleic acid (PNA) is a synthetic DNA analog in
which the phosphodiester backbone is replaced with an N-
(2-amonoethyl)glycine chain so that it is resistant to
nuclease cleavage. However, nucleobases of PNA are
complementary to its target DNA in the normal AeT and
GeC geometry and form a PNAeDNA complex that is more
stable than a DNAeDNA duplex.1e3 When using a PNA probe
designed to cover the variable region and having
a sequence complementary to the wild type in a PCR, the
PNA probe binds tightly to perfectly matched wild-type DNA
template but not to the mismatched mutant DNA
sequences, which specifically inhibits the PCR amplification
of wild-type DNA without interfering in the amplification of
mutant DNA. It is the so called “PNA-mediated PCR
clamping”.4 This design has been applied to detect onco-
genic K-ras and mitochondrial mutations5e7 as well as some
virulent or drug-resistant mutations in microorganisms,
such as the uidA gene mutation of Escherichia coli and DNA
polymerase gene mutation of hepatitis B virus.8e10
Dual hybridzation probes and melting curve analysis
were also applied in this assay. The dual hybridization
probes comprise a pair of probes labeled with different
fluorescent dyes (a donor and an acceptor), between which
fluorescence resonance energy transfer occurs when the
two probes hybridize to approximate regions of comple-
mentary templates.11 Monitoring the acceptor emission
along with temperature change generates a melting curve
of the probes. To detect DNA variants, the shorter of the
two probes is designed to be positioned over the variable
region. Hence, the shorter probe serves as a sensor because
any change in the DNA sequence in this region results in
a shift in its melting temperature and a change in the
melting curve profile. In the current study, a design
combining PNA-mediated PCR clamp and dual hybridization
probes was applied for detection of drug (amantadine)-
resistant influenza A H1N1 viruses.
To achieve efficient clamping of wild-type amplification,
the probewas designed following a guideline described in our
previous report.12 Briefly, an 18-mer PNA tagged with fluo-
rescein on its N-terminal (Fluorescein-OO-CCCAATTA
TACTTGCGGC)was used as both PCR clamp and sensor probe.
The PNA probe covers the mutation site (underlined; that
cause S to N change at position 31 of M2 protein) of M2 gene
and has a distance of 126 nucleotides from the primer
annealing another strand. Note that the distance may affect
clamping efficiency.13 A DNA probe taggedwith LC-Red640 on
its 30 end (50-GCTTTTGGAAAAAAGCCGATCAATAATCCACAATATCAGGTGCACA-Red640-30) serves as the anchor probe.
PCR Kit (Qiagen, Hilden, Germany). The 20-mL reaction
mixture contained 1 reaction buffer and enzymes provided
by thekit, 0.8mMof eachdNTP, 4.5mMMgCl2, 0.6mMforward
(50-ATGGTGCAGGCAATGAGA-30) and reverse (50-TACTCC
TTCCGTAGAAGG-30) primers, 0.25 mM PNA probe, and 5 mL
viral RNA. The reaction conditions consisted of a 30-minute
incubation at 50 C for RT, 15 minutes at 95 C for activation
of the hot-start Taq polymerase, followed by 45 cycles of
95 C, 30 seconds for denaturation; 52 C, 30 seconds for
annealing, and 60 C (clamping condition) or 72 C (non-
clamping condition), 1 minute for extension. After RT-PCR,
a 10-mL aliquot of the product was mixed with 1 mL of 10 mM
anchor probe and transferred into a capillary tube. The
melting curve was analyzed on a LightCycler v1.0 (Roche
Applied Science) with the following program: 95 C for 60
seconds, 40 C for 30 seconds, slowly increase the tempera-
ture (0.7 C/s) to 90 C and read the fluorescent signal at the
step mode.
One of the advantages of applying PNA-mediated PCR for
monitoring the drug-resistant virus is to detect the mutants
in the existence of wild-type in specimens. Therefore,
different copies of RNA extracted from amantadine-
sensitive strain (A/Taiwan/72458/2007, A/Somomon_Is-
lands/3e/2006-like) and resistant strain (A/Taiwan/10067/
2007, A/Malaysia/862/2007-like) were mixed together and
subjected to the PNA-mediated PCR amplification. The RNA
copies were measured by real-time RT-PCR using ABI 7900
machine. The copy number of sensitive strain was fixed at
2  104 copies/mL, and the copy number of the resistant
strain was varied from 2  104 to 10 copies/mL. Therefore,
the ratio of sensitive to resistant viruses was from 1:1 to
1:2000. Fig. 1 shows the melting curve of the reaction, and
the results demonstrated that the sensitivity of the
detection of amantadine-resistant virus (Malaysia strain) by
PNA-mediated PCR amplification is 1:2000, in which there
were 2  104 copies/mL of RNA from the sensitive strain and
10 copies/mL of RNA from the resistant strain.
To understand whether the clamping of target DNA
derived from the sensitive strain (wild-type) by PNA
increases the detection sensitivity of the resistant strain
(mutant), the same ratio of RNAs were subjected to the
Figure 2. Sensitivity of detecting amantadine-resistant
H1N1 virus by PNA-mediated PCR amplification (non-
clamping). Filled and open arrowheads indicate the melting
peaks of wild-type and mutant, respectively.
256 K.-C. Tsao et al.same real-time RT-PCR without “clamping”. The detection
limitation became 1:20, in which there are 1000 copies/mL
of resistant RNA among 2  104 copies/mL of RNA in the
reaction (Fig. 2).
To assess the efficacy of the novel method for detection
of the amantadine-resistant influenza A H1N1 viruses, 116
clinical specimens collected from 2001 to 2008 were
selected for the evaluation. All of them have been identi-
fied as influenza A H1N1 positive using viral culture,
immunofluorescent assay (typing) and sequencing (subtyp-
ing). PNA-mediated RT-PCR detected 22 specimens con-
taining amantadine-resistant viruses. The sequence
analysis of M gene of these isolates revealed that those 22
viruses have N at position 31 of M2 protein (amantadine-
resistant marker).
According to the different melting curve from that of
amantadine-resistant gene, the PNA-mediated RT-PCR can
also detect the amantadine-sensitive gene. Indeed, 90
specimens were detected as the amantadine-sensitive
influenza A H1N1 virus. Together with the 22 amantadine-
resistant ones, 112 clinical specimens were positive for
influenza A virus. However, 35 out of 116 were positive in
the use of traditional real-time RT-PCR (based on Ct value),
and 55 out of 116 were positive in the use of melting curve
typing method (based on Tm value). The difference in
sensitivity may be attributed to the primers targeting
different viral gene sor the same gene but different
regions. The sensitivity of PNA-mediated RT-PCR targeting
M gene is greater than that of the real-time RT-PCR based
on detection of HA gene which is commonly used is many
clinical virology laboratories.
Most laboratories monitor the drug-resistant viruses by
sequencing the resistant markers from the viral isolate. The
whole procedure takes several days. This study proposes
a novel strategy, PNA-mediated RT-PCR, to monitor the
drug-resistant influenza virus directly from clinical speci-
mens, which only takes a few hours. The method can beapplied to monitor the emergence of drug-resistant viruses
during the treatment course of an influenza virus-infected
patient.
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